Charlson Comorbidity Index (CCI)
Calculate the Charlson Comorbidity Index (CCI) to estimate 10-year mortality risk. Free CCI calculator for healthcare professionals with score breakdown and risk classification.
About This Calculator
About the Charlson Comorbidity Index (CCI)
The Charlson Comorbidity Index (CCI) is a validated, widely-used clinical scoring system that predicts 10-year mortality for patients with multiple comorbidities. Developed by Dr. Mary Charlson and colleagues in 1987 and published in the Journal of Chronic Diseases, it has become the gold standard for comorbidity adjustment in clinical research worldwide. The index assigns weighted scores to 19 medical conditions based on their adjusted relative risk of death, with higher scores indicating greater mortality risk.
The CCI is calculated by summing age points (0 for under 50, +1 per decade from 50-59 through 80+) with weighted condition scores. Conditions are grouped into four weight categories: weight 1 includes myocardial infarction, CHF, peripheral vascular disease, CVA/TIA, dementia, COPD, connective tissue disease, peptic ulcer disease, mild liver disease, and diabetes without complications; weight 2 includes diabetes with end-organ damage, hemiplegia, moderate-severe CKD, any non-metastatic solid tumor, leukemia, and lymphoma; weight 3 includes moderate-severe liver disease; and weight 6 includes metastatic solid tumor and AIDS.
The index has been validated extensively across diverse populations and clinical settings, including the US National Surgical Quality Improvement Program (NSQIP), UK hospital episode statistics, and Indian epidemiological studies. It is commonly used in perioperative risk assessment, oncology prognosis, critical care stratification, and clinical trial adjustments. The CCI is inversely proportional to 10-year survival: a score of 0 corresponds to ~98% survival, while scores of 5+ correspond to less than 21% survival.
Regional Notes
India: The CCI is widely used in Indian tertiary care hospitals and research, with validation studies showing comparable predictive accuracy. It is particularly valuable for assessing surgical risk in elderly Indian patients where multimorbidity is increasingly common.
US: The CCI is integrated into the NSQIP risk calculator and used extensively for Medicare/Medicaid outcome adjustments. It is a standard tool in US healthcare quality measurement and comorbidity adjustment.
UK: The UK National Health Service (NHS) uses CCI in hospital episode statistics for risk stratification. It is recommended in NICE guidelines for perioperative risk assessment and long-term condition management.
Frequently Asked Questions
What is the Charlson Comorbidity Index (CCI)?
The Charlson Comorbidity Index (CCI) is a validated clinical scoring system that predicts 10-year mortality for patients with multiple comorbidities. It assigns weighted scores to 19 medical conditions based on their adjusted relative risk of death, with higher scores indicating greater mortality risk.
How is the CCI score calculated?
The CCI score is calculated by summing age points (0-4 based on decade over 50) and comorbidity weights: 1 point each for conditions like MI, CHF, COPD, and diabetes; 2 points for CKD, hemiplegia, and non-metastatic tumors; 3 points for severe liver disease; and 6 points for metastatic tumors and AIDS.
What does a CCI score of 0 mean?
A CCI score of 0 indicates no significant comorbidities and an estimated 10-year survival rate of approximately 98%. This represents very low mortality risk and is typically associated with younger patients without chronic medical conditions.
What is considered a high CCI score?
A CCI score of 5 or higher is considered high risk, with estimated 10-year survival dropping below 21%. Scores of 3-4 indicate moderate risk (53-77% survival), while scores of 1-2 indicate low risk (90-96% survival). The index helps clinicians stratify patients for treatment planning.
Is the CCI used internationally?
Yes, the Charlson Comorbidity Index is used worldwide in clinical research and practice across the US, UK, India, and other countries. It has been validated in diverse populations and is commonly used in perioperative risk assessment, oncology, critical care, and epidemiological studies globally.
Can the CCI be used for all age groups?
The CCI is designed for adult patients. Age adjustment begins at 50 years, adding points for each subsequent decade. For patients under 50, only comorbidity weights apply. The index is most commonly used in middle-aged and older adult populations where multimorbidity is more prevalent.
What is the difference between CCI and other comorbidity indices?
The CCI is the most widely validated comorbidity index, focusing on 19 conditions with differential weights. Other indices like the Elixhauser system use more conditions with different weighting. The CCI is preferred for mortality prediction, while the Elixhauser is often used for length-of-stay and hospital resource utilization.
Should clinical decisions be based solely on CCI?
No. The CCI is one component of clinical assessment and should not be used alone to guide patient care. It does not replace comprehensive clinical evaluation, diagnostic testing, or professional medical judgment. Results should be interpreted by a qualified healthcare professional in the context of the full clinical picture.